NCT05656391View on ClinicalTrials.gov

Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

August 16, 2021

Study Completion Date

August 16, 2021

Conditions
Ulcerative Colitis in Remission
Interventions
DIETARY_SUPPLEMENT

Treatment vs control bread

Consumption of 200 grams per day of either treatment or control bread for eight weeks

Trial Locations (1)

17007

Hospital Doctor Josep Trueta, Girona

All Listed Sponsors
lead

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

OTHER

NCT05656391 - Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis | Biotech Hunter | Biotech Hunter